Literature DB >> 25354576

Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.

Gaya Spolverato1, Yuhree Kim, Sorin Alexandrescu, Irinel Popescu, Hugo P Marques, Luca Aldrighetti, T Clark Gamblin, John Miura, Shishir K Maithel, Malcolm H Squires, Carlo Pulitano, Charbel Sandroussi, Gilles Mentha, Todd W Bauer, Timothy Newhook, Feng Shen, George A Poultsides, J Wallis Marsh, Timothy M Pawlik.   

Abstract

BACKGROUND: The role of surgical resection for patients with large or multifocal intrahepatic cholangiocarcinoma (ICC) remains unclear. This study evaluated the long-term outcome of patients who underwent hepatic resection for large (≥7 cm) or multifocal (≥2) ICC.
METHODS: Between 1990 and 2013, 557 patients who underwent liver resection for ICC were identified from a multi-institutional database. Clinicopathologic characteristics, operative details, and long-term survival data were evaluated.
RESULTS: Of the 557 patients, 215 (38.6 %) had a small, solitary ICC (group A) and 342 (61.4 %) had a large or multifocal ICC (group B). The patients in group B underwent an extended hepatectomy more frequently (16.9 vs. 30.4 %; P < 0.001). At the final pathology exam, the patients in group B were more likely to show evidence of vascular invasion (22.5 vs. 38.5 %), direct invasion of contiguous organs (6.5 vs. 12.9 %), and nodal metastasis (13.3 vs. 21.0 %) (all P < 0.05). Interestingly, the incidences of postoperative complications (39.3 vs. 46.8 %) and hospital mortality (1.1 vs. 3.7 %) were similar between the two groups (both P > 0.05). The group A patients had better rates for 5-year overall survival (OS) (30.5 vs. 18.7 %; P < 0.05) and disease-free survival (DFS) (22.6 vs. 8.2 %; P < 0.05) than the group B patients. For the patients in group B, the factors associated with a worse OS included more than three tumor nodules [hazard ratio (HR), 1.56], nodal metastasis (HR, 1.47), and poor differentiation (HR, 1.48).
CONCLUSIONS: Liver resection can be performed safely for patients with large or multifocal ICC. The long-term outcome for these patients can be stratified on the basis of a prognostic score that includes tumor number, nodal metastasis, and poor differentiation.

Entities:  

Mesh:

Year:  2014        PMID: 25354576      PMCID: PMC4834710          DOI: 10.1245/s10434-014-4223-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome.

Authors:  Manousos M Konstadoulakis; Sasan Roayaie; Ilias P Gomatos; Daniel Labow; Maria-Isabell Fiel; Charles M Miller; Myron E Schwartz
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

3.  Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer.

Authors:  M Raderer; M H Hejna; J B Valencak; G V Kornek; G S Weinländer; E Bareck; J Lenauer; T Brodowicz; F Lang; W Scheithauer
Journal:  Oncology       Date:  1999-04       Impact factor: 2.935

4.  The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.

Authors:  W G Cance; A K Stewart; H R Menck
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

5.  Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.

Authors:  Timothy M Pawlik; Keith A Delman; Jean-Nicolas Vauthey; David M Nagorney; Irene Oi-Lin Ng; Iwao Ikai; Yoshio Yamaoka; Jacques Belghiti; Gregory Y Lauwers; Ronnie T Poon; Eddie K Abdalla
Journal:  Liver Transpl       Date:  2005-09       Impact factor: 5.799

6.  Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.

Authors:  Kelvin K Ng; Jean-Nicolas Vauthey; Timothy M Pawlik; Gregory Y Lauwers; Jean-Marc Regimbeau; Jacques Belghiti; Iwao Ikai; Yoshio Yamaoka; Steven A Curley; David M Nagorney; Irene O Ng; Sheung Tat Fan; Ronnie T Poon
Journal:  Ann Surg Oncol       Date:  2005-03-31       Impact factor: 5.344

Review 7.  The epidemiology of cholangiocarcinoma.

Authors:  Yasser Shaib; Hashem B El-Serag
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

8.  Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Yoshikazu Morimoto; Yasuhiro Tanaka; Toshinori Ito; Masaaki Nakahara; Hiroyuki Nakaba; Toshiro Nishida; Masahiro Fujikawa; Toshikazu Ito; Shigetaka Yamamoto; Toru Kitagawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

9.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

Authors:  Yasser H Shaib; Jessica A Davila; Kathryn McGlynn; Hashem B El-Serag
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  23 in total

Review 1.  Staging of intrahepatic cholangiocarcinoma.

Authors:  Sean M Ronnekleiv-Kelly; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

Review 2.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

Review 3.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

4.  Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases.

Authors:  Shin Hwang; Young-Joo Lee; Gi-Won Song; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-03-28       Impact factor: 3.452

5.  Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients.

Authors:  Simone Conci; Andrea Ruzzenente; Michele Simbolo; Fabio Bagante; Borislav Rusev; Giulia Isa; Rita T Lawlor; Corrado Pedrazzani; Calogero Iacono; Alfredo Guglielmi; Aldo Scarpa
Journal:  Updates Surg       Date:  2020-02-04

6.  Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

7.  Prognostic Impact of Tumor Multinodularity in Intrahepatic Cholangiocarcinoma.

Authors:  Pietro Addeo; Issam Jedidi; Andrea Locicero; François Faitot; Constantin Oncioiu; Alina Onea; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2018-11-26       Impact factor: 3.452

8.  Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma.

Authors:  Mustafa Raoof; Sinziana Dumitra; Philip H G Ituarte; Laleh Melstrom; Susanne G Warner; Yuman Fong; Gagandeep Singh
Journal:  JAMA Surg       Date:  2017-05-17       Impact factor: 14.766

9.  Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas?

Authors:  Fangqiang Wei; Chen Lu; Liuxin Cai; Hong Yu; Xiao Liang; Xiujun Cai
Journal:  Surg Endosc       Date:  2016-12-28       Impact factor: 4.584

10.  Is Surgical Resection Justified for Advanced Intrahepatic Cholangiocarcinoma?

Authors:  Tomoaki Yoh; Etsuro Hatano; Kenya Yamanaka; Takahiro Nishio; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Liver Cancer       Date:  2016-09-14       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.